LifeMD will initially give 29 million AT&T wireless and fiber customers complimentary access to its virtual care and pharmacy platform, with additional markets joining in January 2027 as the benefit expands nationwide. Investors receive a defined rollout, waived membership fees and usage-based charges for visits, prescriptions and services.
Key Highlights
- The $19 monthly membership fee will be waived, representing a stated annual value of $228.
- Customers pay only for visits, prescriptions or other services they use.
- LifeMD and AT&T are providing eligible wireless and fiber customers with complimentary LifeMD membership.
The $19 monthly LifeMD (NASDAQ: LFMD) membership fee is fully waived, representing an annual value of $228. Customers must enroll, then pay only for visits, prescriptions or other services they use. A joint steering committee will oversee marketing, budgets, creative work, pricing, performance and dispute resolution.
Virtual Care Uses Set Customer Charges Available
services include virtual primary care, urgent care, chronic-condition medications, weight management, women’s health, men’s health, prescription dermatology, hormone health, sleep care and laboratory services. Many medications can be shipped through LifeMD’s pharmacy, while others can be sent to a customer’s local pharmacy.
FAQs
Q: What is the LifeMD AT&T partnership?
A: LifeMD and AT&T are providing eligible wireless and fiber customers with complimentary LifeMD membership. The benefit includes access to virtual care and pharmacy services through enrollment.
Q: How much does LifeMD membership cost for eligible AT&T customers?
A: The $19 monthly LifeMD membership fee is waived for eligible AT&T customers. Customers still pay for the visits, prescriptions and other services they use.
Q: When will the LifeMD AT&T benefit expand nationwide?
A: The article does not state when the LifeMD AT&T benefit will expand nationwide. It states that the $19 monthly LifeMD membership fee is fully waived, and customers must enroll before paying for the visits, prescriptions or other services they use.
Download Free Report – Explore 3 Stock Ideas & Industry Insights
Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.
All investments involve risk—consider independent advice before making any investment decisions.
View 3 Research Reports
Disclaimer:
Kalkine Equities LLC, with Delaware File Number 4697384, Foreign Qualification Registration in California File Number 202109211078, and Texas File Number 805521396, is authorized to provide general advice only. The information on https://kalkine.com/ does not take into account any of your investment objectives, financial situation or needs. You should consider the appropriateness of advice taking into account your own objectives, financial situation and needs and seek independent financial advice before making any financial decisions. The link to our Terms and Conditions and Privacy Policy has been provided for your reference. On the date of publishing the reports (mentioned on the website), employees and/or associates of Kalkine do not hold positions in any of the stocks covered on the website. These stocks can change any time and readers of the reports should not consider these stocks as advice or recommendations later.